DockStream: a docking wrapper to enhance de novo molecular design

Jeff Guo1, Jon Paul Janet2, Matthias R Bauer3

  • 1Molecular AI, Discovery Sciences, R&D, AstraZeneca, Gothenburg, Sweden.

Journal of Cheminformatics
|November 18, 2021
PubMed
Summary

REINVENT 2.0 now integrates structure-based docking via DockStream, enhancing de novo drug design. This approach overcomes quantitative structure-activity relationship (QSAR) model limitations, improving active compound generation for drug discovery.